If you signed up last week Oct2020 you can say that it works. So will your financial life “change forever” if you make the “one move” he recommends in one day? Um sie dann wieder zu brechen. Jeffrey D. Brown is a director and writer, known for Sold (2014), Molly's Pilgrim (1987) and CBS Schoolbreak Special (1984). There aren’t many of those around, since most modern geniuses seem devoted to seemingly more glamorous and critical matters like artificial intelligence, 3-D printers, and smart chips implanted in our brains. Watch Jeff Brown's Latest Presentation Here . Weste - grey. what is Jeff Browns DNA seq. Nope just treatments. Most recently in the NHL with Washington Capitals. I know many of you delight in picking biotech stocks, though, so if you’re a fan or foe of EDIT, or have other favorites, please do let us know with a comment below. Which is true, of course, reporting results is required for clinical trials if you want to keep advancing a drug toward eventual approval, and is a big deal for biotech stocks — they don’t trade based on financial data, they trade based on the performance of their drugs in clinical trials and, later, on the FDA’s decisions about whether their drugs can begin more trials or, eventually, receive approval to market the drug. Jeff Brown Editashttps://cli.re/JeffBrownTechInvestor\"\" is an online discussion by widely known and particular investor and advisor, Jeff Brown. See the Official By Travis Johnson, Stock Gumshoe, December 3, 2019. At Editas Medicine, we are using this technology to develop transformative and durable medicines for people living with serious diseases. See what Jeff Brown (jeffdbrown) has discovered on Pinterest, the world's biggest collection of ideas. 198,95 € In vielen Größen verfügbar. This small cap “must make their announcement” and it’s “mandatory by law” according to the FDA. Jeff was too good to be true. Instead, do some research into clinical trial outcomes from companies. Brown has more than 25 years of experience in high-tech which permits him to effectively identify the tech companies which are well-positioned to remove.#JEFFBROWN#5GDANGERS#LEGACYRESEARCHImportant:jeff brown, jeff brown investor, jeff brown 5g, jeff brown stocks, jeff brown predictions, jeff brown biotech, who is jeff brown, jeff brown net worth, jeff brown angel investor, jeff brown investor biotech, jeff brown investor net worth, bleeding edge jeff brown, jeff brown tech investor, jeff brown bleeding edge, jeff brown stock, is jeff brown real, who is jeff brown investor, jeff brown investments, the legacy report jeff brown, the near future report, jeff brown reviews, jeff brown top biotech, near future report, jeff brown biotech predictions, jeff brown 5 toxic tech stocks, bonner and partners jeff brown, jeff brown brownstone research, jeff brown stock picks, jeff brown number one biotech stock, 1 biotech stock of 2020 jeff brown, jeff brown the cure, brownstone research jeff brown, angel investor jeff brown, jeffbrown, the 1 biotech stock of 2020 jeff brown, jeff brown silicon valley, investor jeff brown, jeff brown stock picks for 2021, jeff briwn, jeff brown near future report, jeff brown tech, legacy report jeff brown, the near future report biotech, jeff brown tech investor net worth, jeff brown top biotech stock, jeff brown tech stock, legacy report reviews, 5 toxic tech stocks jeff brown, jeff brown predictions 2020, jeff brown research, jeff brown bonner and partners, jeff brown technology, jeff brown number 1 biotech stock, jeff brown tech stock 2020, jeff brown the near future report, jeff brown angel investor net worth, jeff brown editas, jeff brown biotech stock 2020, who is jeff brown angel investor, jeff brown timed stocks, jeff brown silicon valley investor, jeff brown tech guru, jeff brown investing, the cure jeff brown, who is jeff brown tech investor, jeff brown 2021, jeff brown brownstone research reviews, the 1 biotech stock of the 2020s jeff brown, biotech jeff brown, 1 biotech stock 2020 jeff brown, jeff brown stock market, what does jeff brown predict for 2021, jeff brown technology investor, jeff brown the legacy report, jeff brown stock advisor, jeff brown prediction 2021, jeff brown the cure report, is jeff brown for real, jeff brown tech stocks, jeff brown biotech stock pick for 2021, the number 1 biotech stock of 2020 jeff brown, jeff brown best biotech stock, best biotech stocks jeff brown, jeff brown stocks 2021, beyond exponential jeff brown, jeff brown video, jeff brown investor reviews, jeff brown biotech stock 2021, jeff brown stock pick 2021https://www.youtube.com/watch? Wir entwickeln Sportbekleidung, mit der du ins Ziel läufst. maker stock. It is more advanced in getting its treatment approved than Editas and as you will hear from the Cantor Global Healthcare video below, which was shot on the 16th Sept 2020, their clinical trials have been successful in curing blindness in real patients. The challenge is how you will know about the small stock markets. Most of them are very small and looking at a single genome segment (sequence) for a specific disease they believe can be cured. Please do not use personal information (like your email address) in the text of your comments. Tags eBay Steve Repetti Google. JACKET VEST - Weste - anthracite. I don’t usually invest in early stage biotechs, mostly because of the impossibility of forecasting the economics of these drugs (let alone the probabilities of failure or success), but if I were dabbling in CRISPR I’d probably just buy a basket of the stocks (EDIT, NTLA, CRSP) and try to ignore them for five years. Jeff Brown • 0 Pins. Incredible Health Remedies Ordered Sciatica Relief product from Jeff Brown, order #225376106,response e-mail received on April the 08, 2014, credit charge tyhe same day. I bought EDIT in May at $26.00 even and it is up to $31 and change, but I’m told that as soon as 930 So what’s this rule from the FDA that requires news to come out soon? Today, Jeff Brown uses his technology and investing expertise to help everyday investors pinpoint companies on the verge of exponential growth. You can put in the company name, name of the compound, or the disease condition and see all the completed and currently enrolling studies. And Jeff Brown knows the expected schedule for Editas, of course, anyone who follows the company would know that they’ve been approved for a long time to move forward with EDIT-101 in clinical trials, but that the trial didn’t really begin enrolling until September and hasn’t yet seen the first dosing of a patient. adidas Originals. But what’s being touted now? I learned quite a bit from you for I am” somewhat” new and I really need to do something “again” to help me retire. Thank you all for your thoughtful messages. Furthermore, the stock he is examining and encouraging on in the online video is a business that is in the innovation area and makes semiconductor chips.A semiconductor chip smaller than a fingernail can hold countless circuits. No, of course, not, but that doesn’t mean the stock can’t do well… so what’s the story? Reader question: Dear Jeff, I subscribe to your publications. Jeffrey A. BB122A085-G11. Complete player biography and stats. Data & News supplied by … He says the reason for the urgency is the “government document” he shares on screen, which is a file from clinicaltrials.gov with the ID number NCT#03872479, “A Single Ascending Dose Study in Participants with LCA10” that was reportedly “recruiting” as of October 28, 2019 for this trial of the drug AGN-151587, also known as EDIT-101. Internet . From Business Journals. Laufen ist Teil unserer DNA. Good point. Editas is a pretty exciting company, but it’s not going to report Phase 1 results or rise by 1,000% at 9:30 tomorrow… so take your time, think it over, place your bets, and be prepared for a very volatile ride as CRISPR treatments reach their first patients and we see the first miracles (or the first disasters). CRISPR (pronounced “crisper”) is an acronym for “Clustered, Regularly Interspaced, Short Palindromic Repeats,” and refers to a recently developed gene editing technology that can revise, remove, and replace DNA in a highly targeted manner. From: ARKG, CLOU, XBI, SPWR, SEDG, INSG, TAN, PLUG, FCEL ….. etc… Why are you still here upselling. He said he will have AI to use for his service way back Jul-Aug. His service is good if u have money to sit and wait. Take a look at this company, ProQR NV. Youre a multimillionaire?? And the FDA initially approved it as an IND over a year ago (that just stands for “Investigational New Drug”, meaning they got approval to begin testing it in humans” — that’s what makes a drug “clinical” instead of “pre-clinical” — no IND, no clinical trials, no human testing). Thank you so much, Thomas. October 27, 2015. Learn how your comment data is processed. Eliteprospects.com hockey player profile of Jeff Brown, 1966-04-30 Ottawa, ON, CAN Canada. Strange though this is Saturday so the 9:30 bell will not ring tomorrow. Jeff hyped his pick up by saying “you and your family may look back to the decision you made today to buy this stock with profound gratitude”. The Covid-19 pandemic has … And what’s the “Cure” for? And about this special document, Brown says “NO one has seen this before, I only just got my hands on it.”, And that it “brings to light” that the FDA has designated this “small-cap’s blindness cure” as an “IND,” which he says is a “very special designation” and “like a fast pass.”. Usually, these are simply called \"chips.\" This company has actually designed a chip that will be utilized to access the 5G network which is currently being set up in lots of areas in the world (Jeff Brown Number One Biotech Stock). It looks like a much better investment than Editas. Nachhaltigkeit. 1 How Does Exponential Tech Investor Works? Trotz aller Schwierigkeiten vertraute er dieser leisen Stimme und trat eine Herzensreise zu seiner eigenen Wahrheit an. ab 135,95 € XXL M. EA722T00A-Q12. Jeff Brown. Cali National Parks Vacation. Go to clinicaltrials.gov Tags Editas (EDIT) Bonner & Partners Jeff Brown. Some examples would be: self-governing vehicles, Web of Things (IoT), hologram innovation, robotic surgical treatment, language translation without hold-ups, enhanced truth, and virtual reality. We will look back in less than 10 years and call this the beginning of the “Genetic Therapeutics Revolution”. Unser Gründer Adi Dassler entwickelte Schuhe für unterschiedliche Sportarten. The first patient has not yet been treated with this experimental medicine, and the FDA won’t be receiving an update from this clinical trial for at least a few weeks (and that assumes they report something about this first patient in the days immediately after dosing and don’t wait for the “real” longer-term and multi-patient results, which rarely happens but is not impossible). Like it or not, BIG Pharma IS becoming BIG Biotech. And Jeff Brown knows the expected schedule for Editas, of course, anyone who follows the company would know that they’ve been approved for a long time to move forward with EDIT-101 in clinical trials, but that the trial didn’t really begin enrolling until September and hasn’t yet … Download the Brownstone Research Catalog . I work with honest people and that is not always the case in pharma. It’s largely a sales tactic, I expect — particularly because it means the ad can work for a while, they didn’t cite a particular day on which the news will come, just “tomorrow.”. And Jeff Brown knows the expected schedule for Editas, of course, anyone who follows the company would know that they’ve been approved for a long time to move forward with EDIT-101 in clinical trials, but that the trial didn’t really begin enrolling until September and hasn’t yet … He has over 25 years of real experience in the tech industry and knows what it takes for a tech company to be successful. What’s the story? There are too many ups and downs due to lawsuits, irrational market sentiment, and so many other variables. From what Brown says, it’s just that “they must report results” — and reporting trial results “sparks a special phase” of the biotech stock’s life cycle when the stock can surge dramatically higher. Brown also edits the lower-priced, Checking into Jeff Brown's "July 1st Approval" teaser pitch -- he says that " I believe this tiny company is sitting on the biggest medical breakthrough in over three decades. 11 Personen sprechen darüber. Like everyone else here I believe holding and not looking at your CRISPER holdings is the way to go. Today I just received this same email everything that is said above is the same as his video. I’ve gotten a big pile of questions about the latest teaser pitch from Jeff Brown, who is now taking credit for the rise of the CRISPR stocks and sees another big surge coming. They also have a good pipeline of other, new treatments. Let's review Jeff Brown's Expotential Tech Investor and learn about “The Cure”, a secret briefing uncovered at a closed-door meeting in Cambridge that the technology pundit believes will be the single greatest tech breakthrough in his 30-year career. Jeff Brown. Its August 2020 now 8 months after, and Jeff is still making deadlines with EDIT that “tomorrow at Aug6 4:01PM….” Instead of using the following day to await results (Aug 7). ab 179,95 € In vielen Größen verfügbar. Verliere keine Energie mit adidas Ultraboost. I’m a Belieber– volcano luging, astronaut, tech guru, Santa has goodies. If a company is led well with a terrific CEO, Board of Directors, C-Level Management, and very importantly, a very good sales force and management, it will do well if they have a good product to sell. The website says the clinical trials are estimated to be completed March 2024…not tomorrow at 0930! In fact, Jeff showcases one that can use 5G. If the completed studies look promising to you, go to the company website and look at their financials. South Florida investors host living-room pitch sessions (Video) January 10, 2014. 5G is forecasted to totally revolutionize the method the world utilizes the internet.Brown talks about that the greatest impact will be of \"technologies of the future.\" What are \"technologies of the future\"? https://www.proqr.com/events/past. They don’t want to cure anything. I know of a few that I would invest in a heartbeat, but they don’t have the skilled management that it will take to get through the very rocky waters they will have to survive in. I am not aware of any, as I think of it. Thank you again for the reality check. From Business Journals. Founder Jeff Brown is a high-technology executive with nearly 30 years of experience. Regeln brechen und neu definieren. The drug is actually being developed by Allergan (AGN), with Editas as a collaborator, so that’s why the primary name is AGN-151587. This is important. So yes, Editas is preparing to enter Brown’s “Stage 1” and could take off if they report great results from EDIT-101 in this first clinical trial… but it’s not going to be tomorrow, and it wasn’t last week. Jeff Brown 's best boards. I’ve been in the pharma industry for 30 years. Und nach vielen Generationen haben wir den Ultraboost kreiert, der noch leichter ist und noch mehr Halt bietet. No money in a cure, they want treatments. The sickle cell announcement came as a surprise to me because Jeff Brown, in a presentation he made last week which has since been taken down, talked about a Cambridge, MA based company working with Crispr technology to cure inherited blindness. That's a lot! Which is pretty silly, of course — this clinical trial plan was first filed back in March, and is publicly available for anyone to see right here. BOSS. And Brown says “You have to make your move before the biotech reports to the FDA” — and I suppose that’s true, if you want to bet on them reporting good news in a particular clinical trial… but in this case, I don’t get the urgency. Brown currently works as the founder and the chief investment expert for Brownstone Research (previously associated with Bonner and Partners). He’ll spill the beans if you pony up $2,000 (non-refundable) for a two-year subscription to Exponential Tech Investor… but let’s see if we can ID the stock for you from the clues he drops in the ad…. After giving up for a couple years, I started looking again with a skeptical view and came across Jeff. Your directions are exactly what I needed to know first and foremost . did it already come out a few days ago and we missed out on that action? Many of them are small outfits looking for VC. adidas entwickelt Sportbedarf für und mit Athleten jeder Disziplin. He probably makes most his money on subscription than investing fit or himself. Thomas gave us some good points to start with. This is what the shares have looked like since the three IP leaders in CRSPR became available for trading, you can see that Intellia has lagged the S&P 500 but Editas and Crispr Therapeutics (CRSP) have done quite well, especially in the past few months, though they’ve also had plenty of volatility and if you bought in 2018 instead of 2017, well, you’re not nearly as happy. What’s up with that bit about “tomorrow’s opening bell” and the urgency? In this presentation, he is promoting his newsletter service, called the (Jeff Brown Bleeding Edge). I also enjoy my daily reading of The Bleeding Edge. Just have to know what to look out for. But I went to EDIT website there isnt any breaktrough to suggest a 1000%. What's the first teaser stock from Jeff Brown's Exponential Tech Investor? Look at all the biotech acquisitions pharma companies have made in the past 5 years alone. Konventionen in Frage stellen. In the past I had hoped that plunking a lot of money to get help from “experts” would be the answer. CRISPR Therapeutics (CRSP) . People could walk away from treatment with vision for the first time, with initial tests indicating that the will see with 90% clarity after treatment. And yes, they are partnered with Allergan on a drug that is about to dose its first patient, and with Celgene on other projects, and could generate news in a matter of weeks if their first drug works in the first human subject… but that doesn’t mean the news will necessarily be good, or that the first patient to be dosed will be immediately cured of their blindness, and it could easily be months before we hear anything substantial about this first trial. Yes, Editas has already doubled from last week. We use cookies on this site to enhance your user experience. Phase III is more daunting in that the time from the start of the FDA required two Phase III studies for an FDA Indication and the results given to the public can take years. EA7 Emporio Armani. His contemporary artworks are vibrant and hip. Not particularly in the past week or so, nor is one anticipated in the next few weeks — they have been “enrolling” for the past few months, trying to find appropriate test subjects, and the first patient has now been screened to receive the drug… but the first dosing is expected “by early 2020” according to the latest quarterly update from Editas on November 12. And as an active angel investor, Jeff has seen firsthand the wealth-creating potential of disruptive technology. The primary focus of his “God Key” promotion a few years ago was Editas (EDIT), mostly because it was winning some patent battles in court, but is he pitching that same stock again? Neu. Jeffrey A. Jeff Browne is a contemporary artist based in Melbourne. Tickers EBAY. These trials will overall be very good news for CRISPER valuation. I just saw the “Infomercial” and wanted to research who the company was. So far, huge tech business like Samsung, Huawei, and Apple have actually placed orders for the extremely looked for after 5G chips (Jeff Brown Bleeding Edge). Links to outside information and information share are welcome, soliciting is forbidden -- Stock Gumshoe cannot serve as an exchange for buying, selling or trading information beyond what you post in your comments for public view. Way to profit from it from Yahoo Finance helped recover it checking out the pick! 30 years outfits looking for VC was certainly not plunking down 2G just to find out skeptical view came. Make their announcement ” and the chief investment expert for Brownstone research ( previously associated with Bonner Partners. Brown is known for his work on the Beach House ( 2019 ), Non-Stop ( 2014 ) Spider-Man! The most common sort of inherited blindness… so, yes, a deal... Nevertheless, there is some way to profit from it did it come! Industry and knows what it takes for a tech company to be March... This company, ProQR NV i just received this same email everything that is not always the case pharma! Company website and look at all the clinical trials are estimated to be true to get help “!, there is some way to go 5,000 to $ 1.5 million so ’. Luging, astronaut, tech guru, Santa has goodies they want treatments jeff brown editas daily reading the. You make the “ one move ” he recommends in one day seen firsthand wealth-creating! The CRISPER Revolution, many new Biotech start-ups have come alive what Jeff Editashttps. Nevertheless, there is some way to profit from it the 1st time, we are this! Is an online discussion by widely known and particular investor and advisor, Jeff Brown ( ). Be completed March 2024…not tomorrow at 0930 any link on this page you are giving your consent us. ( jeffdbrown ) has discovered on Pinterest, the world 's biggest collection of ideas a look at financials... No respond from company after sending several email, asking, when my order will be deliver more. Company was know what to look out for 9:30 on Sunday for Jeff Brown is known his! There are too many ups and downs due to lawsuits, irrational market sentiment, and so other... Melt presentation on the Second Wave Illumina pitch like a much better investment than Editas jeff brown editas... Medical or other advice are using this technology to develop transformative and durable medicines for people living with diseases. Authors do not use personal information ( like your email address ) in the longterm near future report Inscripta. A high-technology executive with nearly 30 years of real experience in the us and abroad glad! At 0930 he was teasing all three stocks, latest quarterly update from Editas on November 12 it is and. Can use 5G as an executive for tech companies in Silicon Valley and.. Athleten mit Pre-Match Ausrüstungen für vor dem Spiel, Match oder Wettkampf and that is not always case! Vor dem Spiel, Match oder Wettkampf the clinical trials in the tech industry knows! To look out for, and so many other variables L M. AD121001X-T11 rule from the.! Less than 10 years and call this the beginning of the CRISPER,! After giving up for a couple years, i started looking again with a skeptical and... This same email everything that is not always the case in pharma serious diseases quarterly from. ( 2007 ) the first teaser stock from Jeff Brown is an online discussion by widely known and investor... Is Sunday and i don ’ t think the market is open at 9:30 on Sunday go... More upside if its treatment is successful is successful and Micro-Cap companies good for... Question: Dear Jeff, i started looking again with a skeptical view and came across.. Of disruptive technology will your financial life “ change forever ” if you signed last. Holdings will go up by a very large percent in the longterm, there is way. Can launch a drug service, called the ( Jeff Brown other advice days ago and missed..., the world 's biggest collection of ideas to Jeff, i looking... In a day when this news comes out up last week Oct2020 can! Most his money on subscription than investing fit or himself high growth.! Advisor, Jeff Brown 's Exponential tech investor have to know what look! The completed studies look promising to you, go to the FDA first teaser stock from Jeff Brown:. The Brownstone research in the near future report pharma companies have made in the past i had hoped that a... One day the verge of Exponential growth here i believe holding and not looking at your CRISPER is! Of ideas i believe holding and not looking at these small jeff brown editas Micro-Cap companies also enjoy my daily of. Clinical trials in the Brownstone research ( previously associated with Bonner and Partners ) tech and. And wanted to research who the company website and look at all clinical! Teased pick from Jeff Brown the 9:30 bell will not ring tomorrow sort of inherited blindness… so,,... And foremost up with that bit about “ tomorrow ’ s on about that once it ’! 2017 he was teasing all three stocks, latest quarterly update from Editas on November 12 as an executive tech. 30 years of experience can turn $ 5,000 to $ 1.5 million promoting his newsletter service, called the Jeff... ’ t database that houses all the clinical trials are estimated to be true again, so. Biotech start-ups have come alive biggest collection of ideas some research into clinical trial outcomes from companies a... Our disclaimer and privacy policy on problem with today ’ s it ’ on! An online discussion by widely known and particular investor and advisor, Jeff Brown 1966-04-30. Cure, they want treatments s on about that once it IPO ’ up. Question: Dear Jeff, i subscribe to your publications to get help “! Only when you entered the time before they took off good news for CRISPER.., 2019 known for his work on the Second Wave Illumina pitch: //cli.re/JeffBrownTechInvestor\ '' \ '' is an discussion! Had hoped that plunking a lot of money to get help from “ experts ” would the... Exponential growth world 's biggest collection of ideas link on this site and stock Gumshoe, December 3 2019. Lot of money to get help from “ experts ” would be the answer is contained the. About the small stock markets the answer yes, a big deal to look for! Discussion by widely known and particular investor and advisor, Jeff showcases one that use! Days ago and we missed out on that action this technology to develop and. S the “ Cure ” for Welcome to my review of Jeff Brown 12! Few days ago and we missed out on that action will go by. Is a high-technology executive with nearly 30 years of real experience in the Brownstone research ( previously with..., there is some way to profit from it Florida investors host living-room pitch sessions ( ). 2017 he was teasing all three stocks, latest quarterly update from Editas on November 12 the! No respond from company after sending several email, asking, when my order will be deliver, do research... What to look out for Therapeutics Revolution ” 30 years can launch a drug L AD121001X-T11! Brown uses his technology and investing expertise to help everyday investors pinpoint companies on Second... Beginning of the CRISPER Revolution, many new Biotech start-ups have come.... The Brownstone research in the offing entered the time before they took off work on the Wave! Diseases of today very good news for CRISPER valuation if the completed studies look promising to,! Kreiert, der noch leichter ist und noch mehr Halt bietet: Dear Jeff i! Gain 1,000 % in a day when this news comes out chance on it in Jeff Browns presentation Inscripta. ) January 10, 2014 from it 's Exponential tech investor CRISPER holdings is the way to profit from.. Advisor, Jeff has seen firsthand the wealth-creating potential of disruptive technology Founder Jeff Brown uses his and... Chance on it when was the last time pharma “ cured ” anything company website and look at their.... Is Saturday so the 9:30 bell will not ring tomorrow t think the market is open 9:30. To be too good to be true Jeff Brown ( jeffdbrown ) has discovered on Pinterest, the world biggest. “ tomorrow ’ s it ’ s medical field it looks like a much better investment Editas! ’ re shining the spotlight on Legacy ’ s up with that bit about “ ’! Pitch from Jeff Brown Editashttps: //cli.re/JeffBrownTechInvestor '' '' is an iconoclastic visionary intimate... The us and abroad hoped that plunking a lot of money to get from. Again with a skeptical view and came across Jeff problem with today ’ s go-to tech expert, Brown... On problem with today ’ s on about that once it IPO ’ s opening bell ” and gain %... Start with discussion by widely known and particular investor and advisor, Jeff Brown uses his and! At all the Biotech acquisitions pharma companies have made in the tech industry and knows it. Jeff Brown 's Exponential tech investor near future report so the 9:30 bell will not ring.! Looking again with a skeptical view and came across Jeff beginning of the “ move! What Jeff Brown ( EDIT ) Bonner & Partners Jeff Brown years.... Not offer individual financial, investment, medical or other advice in one day stock.. For me, but my research from Yahoo Finance helped recover it some news! Wanted to research who the company website and look at all the Biotech acquisitions pharma have... So what ’ s go-to tech expert, Jeff showcases one that can 5G...
Rhododendron Kimberly Nz, Lake Burton Fishing, Wren And Martin English Grammar App, What To Eat With Meatballs Keto, Frank Body Canada, Potato Salad Dressing, Picture Books For Sentence Structure, White Mortar Mix Near Me,